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I0070
IMPACT OF RIGHT VENTRICULAR CONTRACTILITY 
ON LEFT VENTRICULAR MECHANICS IN PATIENTS 
WITH CHRONIC SYSTOLIC HEART FAILURE
ANNE BERNARD, ERWAN DONAL, FRÉDÉRIC SCHNELL,
CHRISTOPHE THÉBAULT, JEAN-CLAUDE DAUBERT, PHILIPPE MABO
CHU RENNES, Cardiologie, Rennes, France
Background — Cardiac resynchronization therapy (CRT) is a major 
therapy for patients with symptomatic heart failure. Mechanical 
dyssynchrony assessment remains an issue. There is little data 
available with regards to the infl uence of the right ventricle (RV) 
on the left ventricle (LV) mechanical dyssynchrony as assessed by 
echocardiography.
Aims — We sought to assess the impact of RV on LV function and 
dyssynchrony.
Methods — A total of 40 patients with congestive heart failure 
were analyzed. Twenty had RV dysfunction as defi ned by a tricuspid 
annular systolic peak of tissue Doppler (SaRV)<11.5cm/s while 
the remaining 20 had a SaRV>11.5cm/s. All patients underwent 
prospective echocardiography in order to determine RV function, 
LV function, and dyssynchrony.
Results — The two populations were similar regarding diastolic 
function, atrio-ventricular conduction and interventricular 
dyssynchrony. Patients with RV dysfunction had a signifi cantly more 
severe mechanical dyssynchrony within the LV, considering the 
longitudinal component of contraction (130±103ms vs 62±59ms; 
p=0.01). Furthermore, RV function was correlated with LV longitudinal 
contractility (r=0.47; p=0.001). By contrast, RV dysfunction did 
not affect LV radial contraction and dyssynchrony (103±110ms vs 
100±78ms; p=0.5).
Conclusion — Quantitative analysis of RV function is of capital 
importance when assessing LV function and dyssynchrony in patients 
with systolic heart failure. In certain patients, longitudinal LV 
dyssynchrony could well be infl uenced by RV dysfunction.
I0089
CAN THE TRANSTHORACIC ECHOCARDIOGRAPHY 
PREDICT THE EXTRACORPOREAL LIFE SUPPORT 
WEANING?
NADIA AISSAOUI1, BENOIT DIEBOLD1, PASCAL LEPRINCE2, 
JEAN CHASTRE2, EMMANUEL GUEROT1, ALAIN COMBES2
1 HEGP, CARDIOLOGIE, Paris, France
2 GHPS, chirurgie cardiaque, Paris, France
Purpose — Patients with refractory cardiogenic shock can be 
improved by Extra-Corporeal Life Support (ECLS). In some of them, 
a successful weaning can be achieved. The aim of the study was to 
evaluate the ability of transthoracic echocardiographic indices to 
predict this weaning.
Methods — 50 patients with ECLS were daily imaged with varying the 
ECLS output until one day after the weaning. The haemodynamic 
status was assessed with the invasive arterial pressure (pulsed 
pressure or PP), Aortic Doppler VTI, Mitral Doppler E wave (Em) 
and Ejection Fraction (EF). The wall motion was assessed by the 
longitudinal systolic (Sa) and early diastolic (Ea) velocities using 
Speckle Tracking and Doppler Tissue Imaging (DTI) at the mitral 
annulus level.
Results — 15 patients (weaned “W”) were explanted from the 
ECLS while the 26 others (non weaned “NW”) died or required 
ventricular assistance or transplantation. At the time of admission, 
the two groups had similar demographic and clinical (including 
illness severity) characteristics. VTI, EF and Sa are different in W 
and NW since the fi rst day (p<0.01). The fi lling parameters (Em 
and Em/Ea) could not differentiate the two groups. The patient 
behaviour during the ECLS output variations brought additionnal 
informations: an acute decrease of the ECLS output to less than 10% 
was tolerated in all W but only in 50% of NW (p<0.05). Moreover, 
all studied echographic parameters were modifi ed by load changes 
in W patients (p<0.01) but, in NW patients, DTI indices and EF did 
not vary.
Conclusions — The ECLS weaned patients have signifi cantly 
higher aortic VTI, EF and DTI systolic velocities already on the 
fi rst day suggesting that these parameters may help in their 
management.
Patients
E 
(cm. s-1)
Aortic 
VTI 
(cm)
EF 
(%) 
Lateral 
Sa 
(cm. s-1)
Lateral 
Ea 
(cm. s-1)
Weaned 33.7±24.3 6.3±3.5 20±12 5.4±0.8 6.6±2.6
Non 
weaned
39.1±24.7 3.6±2.1 10±7 3.5±0.8 6.4±3.5
p 0.51 0.028 0.01 < 0.01 0.58
Comparison between the W and NW patients
Insuffi sance cardiaque
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I-0094
MODE AND MECHANISMS OF DEATH FOLLOWING 
ORTHOTOPIC HEART TRANSPLANTATION
NICOLAS LELLOUCHE1, MARMAR VASEGHI2, HARRY RITTER2, 
JINGHESH PATEL2, NOEL BOYLE2, MICHAEL FISHBEIN2, 
JON KOBASHIGAWA2, KALYANAM SHIKKUMAR2
1 Hôpital Henri Mondor, Fédération de Cardiologie, Créteil, 
France
2 UCLA Cardiac Arrhythmia Center, Los Angeles, Etats-Unis
Background — Ventricular fi brillation (VF) is the primary mechanism 
of cardiac arrest in the vast majority of sudden death patients. 
Whether similar modes and mechanisms of death can be generalized 
to denervated hearts in orthotopic heart transplantation (OHT) 
patients is unknown.
Objective — The purpose of this study was to determine the mode 
and mechanisms of death in patients who have undergone cardiac 
transplantation.
Methods — We analyzed the outcomes of 628 patients who underwent 
OHT between January 1994 and December 2004. The mode of death 
was classifi ed as either sudden death (SD) or non-sudden death 
(NSD). The fi rst documented rhythm taken at the time of arrest was 
also reviewed to determine the mechanism of cardiac arrest.
Results — During a mean follow up of 76 months, 194 patients 
expired. Of these, the mode of death could be determined in 
116 patients (60%). Forty-one patients (35%) died from SD and 75 
patients (65%) died of NSD. The fi rst documented rhythm of death 
was available in 91 patients (26 SD and 65 NSD). The terminal 
rhythms in patients who died suddenly were: asystole (34%), 
pulseless electrical activity (PEA) (20%), and VF (10%). In NSD 
patients, the terminal rhythms were asystole (73%), followed by VF 
(7%), and PEA (7%), p<0.001 compared to SD patients.
Conclusion — SD represented the mode of death in 35% of OHT 
patients. The main mechanisms underlying SD in this population were 
asystole and PEA, suggesting that denervation of the donor heart, 
among other post-transplant changes, may alter susceptibility to VF.
I0099
HEART FAILURE INTENSIVE MANAGEMENT IN HEART 
FAILURE CLINIC DRAMATICALLY REDUCES HF-
RELATED READMISSION RATE WITHIN THE ONE YEAR 
FOLLOWING THE FIRST ADMISSION FOR HEART 
FAILURE.
STÉPHANE ZUILY1, PATRICK JOURDAIN2, DANIEL DECUP3, 
NELLY AGRINIER4, JEAN LOIRET3, SERGE GROSHENS3, 
FRANCOIS FUNCK2, MICHEL BELLORINI2, YVES JUILLIÈRE1, 
FRANÇOIS ALLA4
1 Brabois Hospital, Department of Cardiology, Vandoeuvre-Les-
Nancy, France
2 Pontoise Hospital, CH René Dubos, Department of Cardiology
Heart Failure Department, Pontoise, France
3 Pontoise Hospital, CH René Dubos, Department of 
medicoeconomic analysis, Pontoise, France
4 Faculty of Medicine, University of Nancy, EA 4003, School of 
Public Health, Vandoeuvre-Les-Nancy, France
Aims — Heart failure (HF) is the leading cause of in-hospital 
admission and an economic burden. After an explosion of new 
treatment options for patients with HF, the guidelines from the 
European Society of Cardiology concluded that HF management is 
a complex issue requiring an organized system of specialist HF care 
so as to improve the health of patients with HF. A dedicated HF unit 
was created in René Dubos hospital in 2002. It associates in-patient 
hospitalization and out-patient units and an education structure. 
The aim of this study was therefore to evaluate the impact of such 
in-hospital HF management unit on HF prognosis.
Methods and results — We conducted a descriptive study of all 
HF-related readmissions in the year after the fi rst admission for HF 
in new patients from January 2000 to December 2007. Chi square 
and linear regression were performed. There were no signifi cant 
differences in terms of age, sex, renal insuffi ciency and diabetes 
mellitus in patients admitted for HF from 2000 to 2006. Since 
the creation of HF management unit, we observed a signifi cant 
decreasing in HF-related readmission rate from 2002 (21.7%) to 
2007 (15.6%) (p<0.0001) whereas there was no difference in this 
rate before the creation of the HF management unit i.e. from 2000 
(32.1%) to 2001 (34.3%) (p=0.58).
Conclusion — We observed that HF-related readmission rate in 
the year following the fi rst admission for HF in new patients was 
dramatically reduced since the HF unit was set up.
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I0109
HEART FAILURE MANAGEMENT IN AMBULATORY 
CARE: WHAT HAPPENS BEYOND HOSPITAL 
DISCHARGE? RESULTS FROM THE DEVENIR STUDY.
PATRICK ASSYAG1, PIERRE CLERSON2, CHRISTINE CONTRE3, 
MAXIME GUENOUN4, IRINA LEURS5, JEAN-FRANÇOIS THEBAUT6, 
PASCAL PONCELET7, ALAIN COHEN-SOLAL8
1 Hôpital Saint Antoine, Paris, France
2 Orgamétrie, Roubaix, France
3 MENARINI, MEDICAL, Rungis, France
4 Cabinet de Cardiologie, Plan De Cuques, France
5 MENARINI, Rungis, France
6 Centre Medical, Sarcelles, France
7 Clinique d’Henin Beaumont, Henin Beaumont, France
8 Hôpital LARIBOISIERE, Paris, France
Heart failure management in ambulatory care: what happens 
beyond hospital discharge? Results from the DEVENIR study.
Objectives — To describe changes in HF treatment implemented by 
the outhospital cardiologist after hospital discharge.
Methods — Cross sectional observational survey with retrospective 
collection of data at hospital discharge. Patients must have been 
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diagnosed with HF and have been hospitalised for HF within the 
previous 18 months. Analysis is restrained to patients having had at 
least one visit with the outhospital cardiologist between discharge 
and beginning of the survey.
Results — 1 452 patients were included by 412 outhospital 
cardiologists. 1170 have had at least one visit by the cardiologist 
between hospital discharge and started the survey (mean delay 
5.76±4.51 months).
 At 
hospital 
discharge
At start 
of the 
survey
Medication 
prescribed 
after 
discharge
Medication 
discontinued 
after 
discharge
Beta-
blocker†
826 
(70.6%)
863 
(73.8%)
87 (25.3%)* 50 (6.1%)**
ACEI†† 807 
(69.0%)
788 
(67.4%)
46 (12.7%)* 65 (8.1%)**
ARB‡ 170 
(14.5%)
210 
(18.0%)
56 (5.6%)* 16 (9.4%)**
*percentages calculated on the number of patients without the treatment 
at hospital discharge or** with the treatment at hospital discharge; 
†metoprolol, nebivolol, bisoprolol, carvedilol; ††captopril, enalapril, 
lisinopril, trandolapril, ramipril, perindopril; ‡candesartan, valsartan 
At hospital discharge, patients at target doses were 10.5%
for betablocker, 50.9% for ACEI and i4.1% for ARB. Doses were increased 
in 25.3% of patients receiving betablockers, in 11.7% of patients receiving 
ACEI and in 10.3% of patients treated with ARB enabling a target dose in 
20.4% of patients with betablockers, and in 83.2% of patients with ACEI or 
an ARB.
Conclusion — Outhospital cardiologists play a critical role in care 
management of HF patients. Not only do they implement but they 
also amplify the care strategies defi ned during hospitalisation; they 
add recommended betablockers or RAAS inhibitors and increase 
the dose of drugs.
I0112
ROUTINE IN-HOSPITAL CARE AND PROGNOSIS 
OF ELDERLY PATIENTS WITH HEART FAILURE
PHILIPPE LE CORVOISIER1, BERTRAND RENAUD2, ISABELLE MAHÉ3, 
JEAN-FRANÇOIS BERGMANN4, DOMINIQUE MOTTIER5, 
PIERRE PFITZENMEYER6, HERVÉ PERCHET7, DAVID ELKHARAT8, 
PATRICK MAISON9, SOPHIE LETULLE1, ALINE SANTIN2, 
ERIC ROUPIE10, JEAN-LUC DUBOIS-RANDÉ11, ELENA PAILLAUD12, 
JEAN-LOUIS LEJONC12, OLIVIER MONTAGNE1
1 Centre d’Investigation Clinique 006 et U955, Groupe Hospitalier 
Henri Mondor, Créteil, France
2 Structure des Urgences, Groupe Hospitalier Henri Mondor-Albert 
Chenevier, Creteil, France
3 Département de Medecine Interne, Hôpital Louis Mourier, 
Colombes, France
4 Département de médecine interne, Hôpital Lariboisière-Fernand 
Vidal, Paris, France
5 Département de médecine interne et de pneumologie, Hôpital 
Cavale Blanche, Brest, France
6 Service de médecine interne gériatrique, 
Hôpital de Champmaillot, Dijon, France
7 Service de cardiologie, Centre hospitalier de Meaux, Meaux, France
8 Service des Urgences, Hôpital Ambroise-Paré, Boulogne 
Billancourt, France
9 Service de Pharmacologie Clinique, Groupe hospitalier Henri 
Mondor-Chenevier, Créteil, France
10 Service des urgences, CHU de Caen, Caen, France
11 Fédération de Cardiologie, Groupe hospitalier Henri Mondor-
Albert Chenevier, Créteil, France
12 Département Médecine Interne et Gériatrie, GH Henri Mondor-
Albert Chenevier, Créteil, France
Most of the studies performed in heart failure (HF) patients have 
been conducted in middle-aged adults. However, patients with HF 
are mainly elderly patients in whom management is complicated 
by comorbid conditions. Little is known about the quality of 
care among this population. The aim of this prospective and 
multicenter study was to describe the in-hospital management 
in routine clinical settings of elderly patients over 75 years 
presenting to the emergency department with pulmonary oedema. 
During the 12-month study period, 398 patients were enrolled 
in 5 French emergency departments. 96% of them had at least 
one major comorbid condition and the prevalence of cognitive 
impairment was high (63% of patients with a Mini Mental State 
Examination<20). Admission in cardiology departments (33.7%) 
was associated with previous cardiologic assessment (OR: 2.32 
[1.33-4.07] ), prior coronary artery disease (OR: 2.39 [1.47-3.87] 
) and elevated troponin (OR: 1.67 [1.03-2.70] ). By contrast, 
cognitive impairment (OR: 0.39 [0.24-0.62] ) was associated with 
non-cardiology department admission>66.3%). 64.1% of patients 
admitted to cardiology department underwent echocardiographic 
assessment versus 23.7% of the others (p<0.01). A preserved 
left ventricular ejection fraction (≥45%) was found in 70.5% of 
patients. Recommended treatments were under-prescribed 
at admission (48.1%) and were more likely to be delivered at 
discharge to patients admitted to cardiology departments (OR: 
1.51 [1.01-2.23]). In-hospital mortality (11.0%) was not associated 
with department speciality. However, the two years survival of 
patients treated with recommended medications at discharge 
was signifi cantly improved compared with patients treated by 
symptomatic drugs.
Conclusion — Routine care of HF was dependant on non-cardiologic 
factors in this elderly population. Our fi ndings suggest that 
the institution of protocols to standardize care could improve 
compliance with guidelines and long-term outcomes.
I0117
IS MANAGEMENT OF HEART FAILURE AT HOSPITAL 
DISCHARGE DIFFERENCIATED ACCORDING 
O THE EJECTION FRACTION? LESSONS FROM 
THE DEVENIR STUDY.
ALAIN COHEN-SOLAL1, PATRICK ASSYAG2, CHRISTINE CONTRE3, 
MAXIME GUENOUN4, PASCAL PONCELET5, PIERRE LOUIS PROST6, 
JEAN-FRANÇOIS THEBAUT7, IRINA LEURS8
1 Hôpital LARIBOISIERE, Paris, France
2 Hôpital Saint Antoine, Paris, France
3 MENARINI, MEDICAL, Rungis, France
4 Cabinet de Cardiologie, Plan De Cuques, France
5 Clinique d’Henin Beaumont, Henin Beaumont, France
6 Discovery-Cascade, Paris, France
7 Centre Medical, Sarcelles, France
8 MENARINI, Rungis, France
Rationale — Heart failure (HF) with preserved LVEF has been 
individualized in the recent years as a specifi c entity, with different 
mechanisms, special baseline characteristics, a poor prognosis and 
no clearly recognized treatment. Recent papers have focused on 
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patients with LVEF between 40% and 50% who could not be clearly 
classifi ed as patients with reduced or preserved LVEF.
Objectives — To describe the management care of patients 
according to the LVEF with special emphasis on patients belonging 
to the “grey zone”.
Methods — Cross sectional observational survey with retrospective 
collection of data at hospital discharge. Patients must have been 
diagnosed with HF and have been hospitalised for HF within the 
previous 18 months. Patients are classifi ed according to the LVEF at 
hospital discharge.
Results — 412 French outhospital cardiologists included 
1 452 patients meeting the inclusion criteria. Management care at 
hospital discharge according to LVEF (known in 1 408 patients) is 
detailed below.
 LVEF<40%
N=792
LVEF 40-50%
N=366
LVEF>50%
N=250
p
ACEI/ARB 91% 90%† 83% 0.002
Beta-
blocker
78% 76%† 64% <0.0001
Loop 
diuretics
90% 83%* 82% <0.001
Spirono-
lactone
29% 19%* 21% 0.0003
Digoxin 16% 15% 21% 0.15
Calcium 
antagonists
9% 18%†* 27% <0.0001
Antico-
agulants
43% 41% 43% 0.64
p by ANOVA with Bonferroni correction; †p<0.05 for comparisons between 
“grey zone” and LVEF>50%; * p<0.05 for comparisons between “grey zone” 
and LVEF<40%. 
Conclusion — This is the fi rst French survey in patients managed by 
cardiologists after hospital discharge for HF. Cardiologists mainly 
care for patients with low LVEF. Treatment at hospital discharge 
is optimal regarding medical classes, with poor differences 
according to EF. Rate of betablockers and ACEI is quite high in 
the group with EF>50%, even if it is lower than in the groups with 
low EF. As a whole, in France, the 40-50% group is managed as 
the<40% one.
I0133
CARDIAC COMPLICATIONS IN MYOTONIC DYSTROPHY
JEAN DOMINIQUE LUPORSI1, PIERRE KAMINSKY2, SARAH LOUIS3, 
BÉATRICE BREMBILLA-PERROT1
1 CHU de Brabois, Cardiologie, Vandoeuvre Les Nancy, France
2 CHU de Brabois, Service Des Maladies Orphelines, Vandoeuvre 
Les Nancy, France
3 Neurology, Nancy, France
Patients (pts) with myotonic dystrophy (MD) were reported as at 
high risk of complete atrioventricular (AV) block or ventricular 
arrhythmias development. The purpose of the study was to evaluate 
the incidence, the signifi cance and the factors of arrhythmias.
Methods — 119 pts, 62 women, 57 men, mean age 45±14 years, 
were examined for a MD; all patients, but 3 were asymptomatic. 
ECG, measurement of left ventricular ejection fraction (EF) at 
echocardiography, 24 hour Holter monitoring, signal-averaged 
ECG (SAECG) and electrophysiological study (EPS) (n=46) were 
obtained.
Results — ECG and Holter monitoring were normal in 67 and 82 pts. 
Standard deviation of mean RR intervals (SDNN) was>50 ms in all 
pts. Late potentials were present in 22 pts and were not correlated 
with spontaneous or induced VT. EF was normal in all but 3 pts 
(60±10%). HV interval was prolonged in 0 of 13 pts with normal 
ECG, 6 of 11 pts with fi rst d AV block, 8 of 10 pts with hemiblock 
(HB), 4 of 7 pts with bundle branch block (BBB) and 3 of 5 pts with 
atrial fi brillation (AF). Paroxysmal AF or fl utter was noted at ECG in 
11 pts, non sustained AF at Holter ECG in 15 pts and AF was induced 
in 17 of 46 pts (37%). Non sustained VT was noted at Holter ECG 
in 3 pts and was induced in 8 of 46 pts (17%). Sick sinus syndrome 
was noted in 5 pts at Holter ECG and in 10 of 46 pts at EPS. During 
follow-up (4.5±4 years), one pt with myocardial infarction died 
suddenly and 8 from respiratory and heart failure; 4 of them had 
AF at time of death. Five other pts developed chronic AF. Five pts 
developed permanent atrial fl utter, requiring ablation. Pace-maker 
was implanted in 25 pts.
Conclusions — AV conduction disturbances were noted only in pts 
with abnormal ECG. Ventricular arrhythmias were rare. The most 
frequent arrhythmia during the follow-up was atrial fl utter or 
fi brillation; careful treatment should be considered because these 
arrhythmias are associated with a high risk of heart failure and 
death.
I0160
THE ABSENCE OF EXERCISE CAPACITY 
IMPROVEMENT AFTER EXERCISE TRAINING 
PROGRAM: A STRONG PROGNOSTIC FACTOR 
IN PATIENTS WITH CHRONIC HEART FAILURE
JEAN-YVES TABET1, PHILIPPE MEURIN1, HELENE WEBER1, 
FLORENCE BEAUVAIS2, ALAIN COHEN SOLAL2, DAMIEN LOGEART2, 
AHMED BEN DRISS1
1 CRCB, Villeneuve Saint Denis, France
2 Hôpital Lariboisière, cardiologie, Paris, France
Background — Exercise training is established as adjuvant therapy 
for chronic heart failure (CHF), but the prognostic value of 
improvement in exercise capacity after exercise training has never 
been evaluated.
Methods — In this prospective bicentric study, all CHF patients 
with left-ventricular ejection fraction (LVEF)<45% who underwent 
an exercise training program in a cardiac rehabilitation center 
between January 2004 and September 2006 were consecutively 
included. Improvement in exercise capacity was assessed by change 
in peak oxygen consumption (ΔPVO2) and in PVO2 expressed as a 
percentage of predicted PVO2 (Δ%PPVO2) measured before and 
after the training program.
Results — We included 155 patients (54±12 years old, male 81%, 
LVEF=29.5±7.1%). Patients underwent 19±9 training sessions. 
PVO2 and%PPVO2 were signifi cantly increased after the training 
program (14% and 13%, respectively, p<0.001 for both). After 
16±6 months follow-up, 27 patients had a cardiac event (death 
[n=12], cardiac transplantation [n=5], hospitalization for acute 
heart failure [n=10]. Univariate analysis revealed that among 17 
signifi cant predictor of cardiac events, the two more powerful 
ones were level of B-type natriuretic peptide (BNP) at baseline 
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(p<0.0001) and improvement in exercise capacity as assessed 
byΔPVO2 and Δ%PPVO2 (p<0.0001). Multivariate analysis revealed 
BNP level and Δ%PPVO2 as only independent predictive factors of 
outcome (p=0.01). The risk ratio of cardiac events for nonresponse 
versus response to the training program (defi ned as median 
Δ%PPVO2<6%) was 8.2 (p=0.0006).
Conclusion — Among patients with CHF, the lack of and BNP 
levelimprovement in exercise capacity after an exercise training 
program completion has a strong prognostic value for adverse 
events indepedent of classical predictive factors such as LVEF, 
NYHA class
I0179
THE UTILITY OF CARDIAC BIOMARKERS 
IN EARLY DETECTION OF CARDIOTOXICITY 
ANTHRACYCLINE-INDUCED 
IN CHILDREN – PRELIMINARY STUDY
CRISTINA GABRIELA MANDRIC1, A.G. DIMITRIU1, INGRID MIRON1, 
IRINA LUCIANA DUMITRIU1, B. GURZU1, MIHAELA MIHAILA2, 
A. COVIC2
1 Université de Médecine and Pharmacie, Iasi, Roumanie
2 ‘C. I. PARHON’University Hospital, Iasi, Roumanie
Background — Cardiotoxicity of the anthracyclines (AN) used in 
therapy of cancer justifi es the attention granted for precocious 
diagnosis and monitoring, in order to reduce this new cardiovascular 
risk factor.
Objectives — Early detection of cardiotoxicity of AN, by specifi c 
biomarkers: cTnI and BNP.Methods.27 patients, aged between 
3-18; evaluation: history and physical; EKG; chest X-ray, 
echocardiography (echo), cardiac biomarkers-BNP, cTnI, ASAT, CPK.
Study lot-divided into 3 subgroups: A-11new cases; B-10 cases with 
subclinical cardiotoxicity echo revealed, cardioprotector treatment 
(enalapril) applied; C-6 cases with chemo-protocol completed, no 
cardioprotector treatment applied.The evaluation-baseline (at 
the beginning of the study) and periodically.The interval between 
measurements — established in accordance to particularities of the 
studied subgroup.
Results — Clinical manifestations: heart failure (1 case), 
untypical clinic manifestation (mild dyspnea, fatigue, asthenia, 
palpitations) — 15 cases; echo modifi cations-6 cases: diastolic 
dysfunction (5), systolic dysfunction (1) of the left ventricle (LV); 
EKG changes-5cases (sinusal tachycardia-2, minor ventricular 
repolarization impairment of LV-3).High values of BNP (cut-off-
100pg/ml) were noticed in 11 patients (4 between 100-200 pg/
ml,7>200pg/ml).cTnI values: all cases were situated under the 
cut-off value of 0.04ng/ml.Increased values of BNP was positive 
correlated with cumulative dose administered of AN.All children 
on cardioprotector treatment had normal values of BNP and cTnI.
At the patients in which high values of BNP were initially found 
(after the fi rst cytostatic administered), later were seen changes 
of echo parameters of the LV. In subgroup B, BNP and cTnI were in 
normal limits.
Conclusions — Our fi ndings demonstrated that modifi cation of BNP 
appear much earlier compare with echo changes.No modifi cation 
of cTnI was obtained.Use of serial BNP and echo studies may 
be an useful and sensitive predictor of high-risk patients for 
cardiotoxicity AN.
I-0221
CENTRAL VENOUS OXYGEN SATURATION 
IS A STRONG PREDICTOR OF OUTCOME IN PATIENTS 
WITH CARDIOGENIC SHOCK
ROMAIN GALLET DE SAINT-AURIN, LAURENS MITCHELL-HEGGS, 
LESLIE DEAL, JEAN-LUC DUBOIS RANDÉ, PASCAL GUERET, 
PASCAL LIM
Hôpital Henri Mondor, Creteil, France
Introduction — Central venous oxygen saturation (SvO2) provides 
an accurate assessment of oxygen delivery and organs consumption 
balance, and is correlated with outcome in extra cardiac shock. 
Its prognosis value has never been specifi cally validated in heart 
failure patients with cardiogenic shock.
Methods — SvO2 was prospectively assessed in 22 patients 
(61±17 years, 15 male, LVEF=22±6%) admitted for heart failure 
with cardiogenic shock. All patients were treated conventionally 
according to the current guidelines. SvO2 before and 24 hours 
(SvO2 24H) after dobutamine infusion was assessed from blood 
sample from a superior vena cava catheter and compared to the 
occurrence of major cardiovascular event defi ned as death and 
heart transplant.
Results — During the hospitalisation period, major cardiovascular 
event occurred in 8 (36%) patients (6 deaths, 2 referred for heart 
transplant). Baseline SvO2 signifi cantly increased after 24H of 
treatment (50±13% vs 60±8%, p=0.03). Sv02 24H correlated with 
urine output (r=0.6, p=0.02) and was higher in patients with 
than without favourable outcome (65±6% vs 53±3%, p<0.001). 
Importantly all patients (100%) with Sv02 24H<60% died or were 
referred to heart transplant, while 83% were event free survival 
when Sv02 was ≥60%. In contrast, BNP level and standard clinical 
and echocardiography features did not correlate with the 
prognosis.
Conclusion — ScvO2<60% after 24 hours dobutamine infusion is a 
strong predictor of mortality in patients with cardiogenic shock.
I0225
FACTEURS PRÉDICTIFS D’UNE DYSFONCTION 
VENTRICULAIRE DROITE 
DANS LA POLYNEUROPATHIE AMYLOIDE FAMILIALE
SOUMIYA L. BENNANI1, VINCENT ALGALARRONDO1, 
SYLVIE DINANIAN1, JULIE GUIADER1, DAVID ADAMS2, MICHEL SLAMA1
1 Hôpital Antoine Béclère, cardiologie, Clamart, France
2 CHU Kremlin Bicêtre, neurologie, Kremlin Bicêtre, France
La polyneuropathie amyloïde familiale associe neuropathie 
périphérique, troubles conductifs, dénervation cardiaque, 
cardiomyopathie hypertrophique et restrictive. L’instabilité 
hémodynamique qui complique fréquemment la transplantation 
hépatique, seul traitement améliorant le pronostic, impose une 
évaluation cardiologique préalable.
Le but de cette étude est d’évaluer morphologie et fonctions 
systolique et diastolique du ventricule droit (VD) chez 35 patients 
en bilan de pré-transplantation, colligés prospectivement entre 
janvier 2007 et août 2008, comparés à 36 témoins, utilisant 
imagerie 2D, doppler et doppler tissulaire.
La FEVG était normale chez tous les sujets (60,1 ± 1,9 % chez les 
patients ; 67,5 ± 1,2 % chez les témoins ; p = 0,001). 48,6 % des 
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patients avaient des pressions de remplissage gauches élevées, (E/
Ea > 10) versus 8,3 % des témoins (p < 0,0001). Le débit cardiaque 
était signifi cativement plus élevé chez les témoins (2,9 ± 0,1 l/mn 
versus 2,5 ± 0,1 l/mn ; p = 0,02).
L’étude de la fonction systolique VD montre un pic systolique 
au DTI à l’anneau tricuspide (11,9 ± 0,5 versus 15,5 ± 0,4 cm/s ; 
p < 0,0001) et une excursion systolique de l’anneau tricuspide en 
TM (18,2 ± 0,7 versus 23,5 ± 0,8 ; p < 0,0001) signifi cativement 
diminués. L’onde Ea tricuspide au DTI était diminuée (10,3 ± 0,8 
versus 13,9 ± 0,6 ; p = 0,001). 50 % des patients avaient un rapport 
E/Ea tricuspide > 6 versus 11,4 % des témoins (p = 0,002). Les 
moyennes de PAPs étaient de 34,6 ± 2,8 pour les patients et de 
26,3 ± 1,2 mmHg pour les témoins (p = 0,007).
En analyse univariée, les paramètres corrélés à une dysfonction 
systolique du VD sont : âge ≥45 ans, valve mitrale épaissie, 
MAPSE≤12 mm, pressions gauches élevées, hypertrophie du septum 
inter-auriculaire ou de la paroi du VD, et pic systolique à l’anneau 
mitral en DTI < 6 cm/s.
Les patients présentant une FAP ont une dysfonction systolique 
et diastolique du VD précoce, alors même que la fonction VG est 
préservée. L’analyse fi ne de la fonction VD permettra une détection 
précoce de cette cardiopathie amyloïde.
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EPIRUBICIN LATE CARDIOTOXICITY 5 YEARS 
AFTER CHEMOTHERAPY FOR BREAST CANCER: 
USEFULNESS OF 2D STRAIN ANALYSIS.
HAFIDA SAMET, ANNIE TRINH, CYRIL COHEN, SONIA LOUBOUTIN, 
GERALD ROUL
Pôle Cardiologie, USI Cardiologie, Strasbourg, France
Aim — To evaluate the 2D strain in the detection of epirubicin (E) 
induced late cardiotoxicity in women previously treated for breast 
cancer.
Method — Pts suffering from breast cancer underwent 5 years 
previously the same treatment protocol including the E followed 
by surgery. They were examined in our department 5 years later. As 
part of their workup, a transthoracic echo was performed recording 
left ventricular (LV) systolic and diastolic function, LV dimensions, 
longitudinal strain over 17 segments and radial strain over 6 middle 
segments in all possible views.
Results — 57 patients and 39 controls (exclusively women; 57±9 vs 
53±13 yrs — NS) were studied. Only one pt experienced congestive 
heart failure 67 months after treatment. Mean dose of E was 
577±78 mg/m² and average delay from chemotherapy 62±18 months. 
Compared to controls, LVEDD was slightly increased in the pts group 
(49±3.4 vs 45±4.8 mm, p<0.0001) and LVEF moderately reduced 
(62±7 vs 68±6%, p<0.0001), though the values remained in the 
normal range. LV relaxation was also signifi cantly prolonged in the 
E treated group. Radial and longitudinal strains were decreased (all 
p<0.05). Moreover, changes in elementary strain were heterogeneous 
in all cases. Mean longitudinal strain was related to LVEF in controls 
and even more so in pts (r=−0.37; p=0.02 in controls and r=−0.52; 
p<0.001 in patients), suggesting that changes in mean longitudinal 
strain bring valuable piece of information in this setting. ROC 
curves showed that LVEDD and mean longitudinal strain were the 
most discriminating parameters between pts and controls further 
underlining the interest of the latter.
Conclusion — E, though used at low dose, is associated with 
a reduction in LV performances in systole and diastole. These 
modifi cations are moderate but stress the need for serial evaluation 
in such pts. Analyzing of the strain seems to add information and 
should be included in routine evaluation of these pts.
